Arvinas (ARVN) Operating Expenses (2017 - 2026)

Arvinas' (ARVN) quarterly Operating Expenses came in at $79.4 million in Q1 2026, down 32.37% year-on-year from $117.4 million in Q1 2025, and down 5.59% quarter-over-quarter from $84.1 million in Q4 2025.

Arvinas (ARVN) Operating Expenses (2017 - 2026) Analysis & Trends

Arvinas' Operating Expenses history runs 10 years deep, the most recent figure standing at $79.4 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 32.37% year-over-year to $79.4 million in Q1 2026; TTM through Mar 2026 was $343.1 million, a 34.33% decrease from a year earlier, with the FY2025 full-year figure at $381.1 million, down 25.8% from the prior year.
  • Operating Expenses declined to $79.4 million in Q1 2026 per ARVN's latest filing, from $84.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $162.7 million in Q3 2024 and bottomed at $79.4 million in Q1 2026.
  • The 5-year median for Operating Expenses is $108.6 million (2024), against an average of $108.8 million.
  • Across the five-year window, Operating Expenses soared 78.39% in 2022 and tumbled 47.33% in 2025, its largest moves.
  • Year by year, Operating Expenses stood at $113.4 million in 2022, then grew by 7.76% to $122.2 million in 2023, then decreased by 3.93% to $117.4 million in 2024, then dropped by 28.36% to $84.1 million in 2025, then decreased by 5.59% to $79.4 million in 2026.
  • Per Business Quant, the three latest ARVN Operating Expenses figures stand at $79.4 million (Q1 2026), $84.1 million (Q4 2025), and $85.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -28.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.10 Bn
4 NuCana 279.75 Bn 279.75 Bn - -3.78 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 32.68 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 2.89 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 445.22 Mn
10 Arvinas 519.68 Mn -95.22 Mn - 79.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 79.40 Mn
Dec 31, 2025 84.10 Mn
Sep 30, 2025 85.70 Mn
Jun 30, 2025 93.90 Mn
Mar 31, 2025 117.40 Mn
Dec 31, 2024 117.40 Mn
Sep 30, 2024 162.70 Mn
Jun 30, 2024 125.00 Mn
Mar 31, 2024 108.60 Mn
Dec 31, 2023 122.20 Mn
Sep 30, 2023 108.50 Mn
Jun 30, 2023 129.10 Mn
Mar 31, 2023 120.20 Mn
Dec 31, 2022 113.40 Mn
Sep 30, 2022 97.50 Mn
Jun 30, 2022 99.60 Mn
Mar 31, 2022 84.20 Mn
Dec 31, 2021 80.70 Mn
Sep 30, 2021 56.60 Mn
Jun 30, 2021 57.40 Mn